Companies: 10,795·Total market cap: $144.5T
Scholar Rock Holding Corporation

Scholar Rock Holding Corporation

SRRKNASDAQHealthcare● Active
$43.75
$-0.55(-1.23%)
Market Cap$5.2B
P/E Ratio
52W High$52.185
52W Low$27.07

Scholar Rock Holding Corporation (SRRK) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

srrk · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Scholar Rock Holding Corporation (SRRK) measures how much investors pay for each dollar of the company's trailing earnings. SRRK's current PE ratio of N/A is calculated by dividing its stock price of $43.75 by its TTM earnings per share of -$3.21.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-2.49
Based on 13 analysts
EPS (TTM)
-$3.21
TTM · diluted EPS
PEG Ratio
0.50
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Scholar Rock Holding Corporation SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2016 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Scholar Rock Holding Corporation
Scholar Rock Holding CorporationYou
SRRK
$5.2BN/A-$3.21
Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation
ADPT
$2.7BN/A-$0.39
Beam Therapeutics Inc.
Beam Therapeutics Inc.
BEAM
$3.0BN/A-$0.81
Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc.
CDTX
$5.6BN/A-$26.75
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc.
IDYA
$2.7BN/A-$1.28
Disc Medicine, Inc.
Disc Medicine, Inc.
IRON
$2.5BN/A-$6.01
Kiniksa Pharmaceuticals, Ltd.
Kiniksa Pharmaceuticals, Ltd.
KNSA
$3.6B51.87x$0.80

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 10 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-3.29
2024-12-31
FY2024
$-2.47
2023-12-31
FY2023
$-2.18
2022-12-31
FY2022
$-2.26
2021-12-31
FY2021
$-3.59
2020-12-31
FY2020
$-2.81
2019-12-31
FY2019
$-1.85
2018-12-31
FY2018
$-3.15
2017-12-31
FY2017
$-1.40
2016-12-31
FY2016
$-0.91

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Scholar Rock Holding Corporation (SRRK) measures how much investors pay for each dollar of the company's trailing earnings. SRRK's current PE ratio of N/A is calculated by dividing its stock price of $43.75 by its TTM earnings per share of -$3.21.

PE Ratio = Stock Price ÷ EPS (TTM)
= $43.75 ÷ -$3.21 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

SRRK pe ratio · 6 questions

SRRK's current PE ratio is N/A as of 2026-06-08, based on a stock price of $43.75 and TTM EPS of -$3.21. Data sourced from Financial Modeling Prep via SRRK's SEC 10-K and 10-Q filings.

SRRK PE ratioWhat is SRRK PE ratioCurrent PE ratio of SRRKSRRK PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Scholar Rock Holding Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08